Phase 1/1b Multicenter Open-Label Study of RMC-6236 in Subjects with Advanced Solid Tumors Harboring Specific Mutations in KRAS

Disease:

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors

Study phase:

Phase I

Physician name:

David Sanghyun Hong

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-877-632-6789